December 2026

Tissueblue

brilliant blue G

Dutch Ophthalmic Research Center International BV

Solution (ophthalmic) · NDA 209569

Last listed protection ends
December 20, 2026

The FDA lists 1 exclusivity for Tissueblue, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Orphan drug exclusivity
    FDA code ODE-282